top
Search terms
Results 1 - 10 of 742 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 75
Ehjournal

Nationwide register dataMyocardial infarctionRisk factorsPrognosisMortality See page 1155 for the editorial comment on this article (doi:10.1093/eurheartj/ehv048) Clinical perspective This ...

European Heart Journal, Acute coronary syndrome, Tomas Jernberg, PÃ¥l Hasvold, Martin Henriksson, Hans Hjelm, Marcus Thuresson, Magnus Janzon

Date : 14/05/2015 Item size : 313858 bytes
Ehjournal

InflammationCoronary artery diseaseAtherosclerosisRheumatic diseaseRheumatoid arthritisSystemic lupus erythematosusRisk factorsIntroduction Recognition of the prominent role of inflammation at all ...

European Heart Journal, Clinical update, Justin C. Mason, Peter Libby

Date : 21/02/2015 Item size : 590553 bytes
Ehjournal

Fortunately, recent studies demonstrated a normalization of the cardiac biomarkers and the functional alterations within a short time frame. [...]these alterations may be perceived as physiological ...

European Heart Journal, Clinical update, Hans-Georg Predel

Date : 21/11/2014 Item size : 435116 bytes
Ehjournal

Controversy only exists as to whether LDL cholesterol target levels or risk-adjusted dosing should be used in their management,5 with the former advocated by the European Society of Cardiology and ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 21/02/2015 Item size : 212610 bytes
Ehjournal

Sodium-glucose cotransporter-2 inhibition for the reduction of cardiovascular events in high-risk patients with diabetes mellitus Nikolaus Marx, Darren K. McGuire European Heart Journal Nov 2016, 37 ...

European Heart Journal, Review, Nikolaus Marx, Darren K. McGuire

Date : 07/11/2016 Item size : 159932 bytes
Ehjournal

Download the Issue @ a Glance podcast Subscribe to the EHJ Podcast The management and, as a consequence, the outcome of acute coronary syndromes or ACS have improved impressively over the last ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 21/04/2016 Item size : 257926 bytes
Ehjournal

In their trial, Cannon et al. report the superiority of the anti-PCSK9 monoclonal antibody (mAb) alirocumab (SAR236553/REGN727; s.c. 75 mg every 2 weeks) over ezetimibe (oral 10 mg once a day) in the ...

European Heart Journal, Editorial, Baris Gencer, François Mach

Date : 14/05/2015 Item size : 244342 bytes
Ehjournal

Blood pressure is one of the cardinal risk factors for atherosclerosis and cardiovascular diseases. Systolic and diastolic blood pressures are measured at the level of the brachial artery, ...

European Heart Journal, Editorial, Thierry C. Gillebert

Date : 21/11/2014 Item size : 188975 bytes
Ehjournal

Standing for healthier lives—literally Since the original study by Morris in 19531 showing that bus conductors in London experienced less coronary heart disease and mortality than bus drivers ...

European Heart Journal, Francisco Lopez-Jimenez

Date : 14/10/2015 Item size : 153800 bytes
Ehjournal

The Framingham study and numerous cohorts thereafter subsequently confirmed the prognostic value of cholesterol and in particular LDL-cholesterol, and the 4S Trial2 eventually proved the cholesterol ...

European Heart Journal, Issue @ A Glance, Thomas F. Lüscher

Date : 14/10/2016 Item size : 197432 bytes